全文获取类型
收费全文 | 143341篇 |
免费 | 48704篇 |
国内免费 | 221篇 |
专业分类
耳鼻咽喉 | 2148篇 |
儿科学 | 6448篇 |
妇产科学 | 2374篇 |
基础医学 | 23120篇 |
口腔科学 | 7244篇 |
临床医学 | 24427篇 |
内科学 | 36136篇 |
皮肤病学 | 8863篇 |
神经病学 | 20151篇 |
特种医学 | 3861篇 |
外科学 | 20358篇 |
综合类 | 466篇 |
现状与发展 | 3篇 |
一般理论 | 89篇 |
预防医学 | 12492篇 |
眼科学 | 2320篇 |
药学 | 8620篇 |
2篇 | |
中国医学 | 1064篇 |
肿瘤学 | 12080篇 |
出版年
2024年 | 290篇 |
2023年 | 1803篇 |
2022年 | 1101篇 |
2021年 | 3494篇 |
2020年 | 7072篇 |
2019年 | 12579篇 |
2018年 | 12619篇 |
2017年 | 13704篇 |
2016年 | 14449篇 |
2015年 | 14450篇 |
2014年 | 15124篇 |
2013年 | 16439篇 |
2012年 | 8813篇 |
2011年 | 8894篇 |
2010年 | 11952篇 |
2009年 | 8435篇 |
2008年 | 5918篇 |
2007年 | 4731篇 |
2006年 | 4779篇 |
2005年 | 4233篇 |
2004年 | 4001篇 |
2003年 | 3721篇 |
2002年 | 3476篇 |
2001年 | 1397篇 |
2000年 | 1060篇 |
1999年 | 813篇 |
1998年 | 887篇 |
1997年 | 755篇 |
1996年 | 682篇 |
1995年 | 615篇 |
1994年 | 451篇 |
1993年 | 437篇 |
1992年 | 310篇 |
1991年 | 254篇 |
1990年 | 220篇 |
1989年 | 213篇 |
1988年 | 197篇 |
1987年 | 146篇 |
1986年 | 149篇 |
1985年 | 156篇 |
1984年 | 141篇 |
1983年 | 130篇 |
1982年 | 153篇 |
1981年 | 150篇 |
1980年 | 121篇 |
1979年 | 76篇 |
1978年 | 85篇 |
1977年 | 63篇 |
1976年 | 54篇 |
1974年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
M. Laurin Council Jennifer M. Gardner Cynthia Helms Ying Liu Lynn A. Cornelius Anne M. Bowcock 《Experimental dermatology》2009,18(5):485-487
Abstract: The risks of developing malignant melanoma (MM) include ultraviolet irradiation and genetic factors. To examine the contribution of rare and common variation within known MM genes in sporadic US MM patients, coding regions of known MM susceptibility genes [cyclin-dependent kinase inhibitor 2A ( CDKN2A ), cyclin-dependent kinase 4, melanocortin 1 receptor ( MC1R ) and tyrosinase ( TYR )] were resequenced in 109–135 MM cases. The significance of variants was examined by comparing their frequencies in 390 cancer-free controls. Potential deleterious mutations in CDKN2A were found in two patients and two others had variants of unknown significance. Cases were more likely than controls to harbour the MC1R 'R' variants known or predicted to alter its function ( P = 0.002), particularly the R160W variant ( P = 0.0035). The associated TYR R402Q variant (rs1126809*A) was found in 29% of cases, similar to what has been described previously. One MM patient with a family history of MM, who had developed other skin cancers, was homozygous for a novel TYR variant (P406L) of unknown significance. Hence, rare variants in TYR may be important risk factors for skin cancer. 相似文献
42.
43.
44.
45.
Jing‐Ping Zhang Limin Zheng Jiang‐Hai Wang Karl‐Eric Magnusson Xin Liu 《Phytotherapy research : PTR》2009,23(6):844-850
Ganoderma sinensis has been used widely in Oriental countries for the prevention and treatment of various diseases including cancer. Previous studies have shown that the lipid extract from Ganoderma exhibits direct cytotoxicity against tumor cells. Here, it is reported that the lipid extract from germinating G. sinensis spores, at lower concentrations that have no direct tumoricidal activity, induce potent antitumor immune responses in human monocytes/macrophages. Upon stimulation with the lipid extract, monocytes/macrophages exhibited markedly increased production of proinflammatory cytokines and surface expression of costimulatory molecules. Conditioned medium from stimulated cells effectively suppressed the growth of tumor cells. Apparently, the lipid extract triggered macrophage activation via a mechanism different from that associated with LPS. Moreover, it was observed that the lipid extract could partially re‐establish the antitumor activity of the immunosuppressive tumor‐associated macrophages. These results indicated that in addition to its direct tumoricidal activity, the lipid extract from G. sinensis spores could exert antitumor activity by stimulating the activation of human monocytes/macrophages. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
46.
47.
48.
Henry Ho‐Lung Chan 《Clinical & experimental optometry》2005,88(6):410-414
The first‐order kernel analysis in multifocal electroretinogram (mfERG) using low contrast stimulation is suggested as a way to detect the inner retinal responses in animal studies. In this case report, this protocol is applied to human patients with glaucoma to demonstrate the possibility of using mfERG as a tool to detect glaucomatous damage. Two patients with glaucoma were recruited and had mfERG measurements with the 103‐scaled hexagonal stimulus pattern at low (50 per cent) contrast. Their responses were analysed and compared with those from normal subjects with the mfERG measured under the same condition. In the normal subjects, there were obvious oscillatory components on the ascending and descending limbs of the first‐order kernel response to 50 per cent contrast. In the glaucomatous patients, the oscillatory component on the descending limb was obviously diminished. In addition, this component was significantly diminished in the quadrant with a glaucomatous visual field defect. This suggests that the low‐contrast stimulation condition in mERG measurement may provide a good way to detect glaucomatous damage and this may help in clinical diagnosis of glaucoma. 相似文献
49.
Skoug John W. Borin Marie T. Fleishaker Joseph C. Cooper Anne M. 《Pharmaceutical research》1991,8(12):1482-1488
The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis of drug release profiles through 60% released using the Peppas equation. Computed values of the diffusional exponent, n, ranged from 0.59 to 0.66. Values of n in this range are consistent with a mixed mechanism of release, with diffusion of drug through the hydrated polymer matrix and relaxation of this matrix being the principal processes controlling release. The rate of in vitro drug release was increased for half tablets relative to whole tablets and is attributed to an increase in the surface to volume ratio of half tablets of about 16%. This increase in surface-to-volume ratio of half tablets was reflected by an increase in the constant, k, from the Peppas equation of 20–23% and by an increase in the slope of Higuchi plots of 12–18% for four lots of tablets. In vivo/in vitro relationships from two bioavailability studies were thoroughly evaluated. Using either a linear or a quadratic relationship, an in vivo/in vitro correlation exists for sustained-release adinazolam mesylate tablets. 相似文献
50.